Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The aim of the study is to evaluate the effect of metformin on myocardial function, insulin resistance and selected metabolic markers in patients with type 2 diabetes and heart failure (HF+DM+) in a cross-over, randomized, placebo controlled trial. Hypothesis: Metformin treatment in HF+DM+ group will lead to better myocardial function and load tolerance in comparison to placebo. The degree of improvement will be linked to selected metabolic parameters.
Epistemonikos ID: e653a849e873eb6dc65401617bb917d3df99ea70
First added on: May 11, 2024